Telix Pharmaceuticals Limited (TLX)
NASDAQ: TLX · Real-Time Price · USD
10.92
-0.37 (-3.28%)
At close: Oct 13, 2026, 4:00 PM EDT
11.13
+0.21 (1.92%)
After-hours: Oct 13, 2026, 7:30 PM EDT
Telix Pharmaceuticals Market Cap
Telix Pharmaceuticals has a market cap or net worth of $3.74 billion as of October 13, 2026. Its market cap has increased by 12.59% in one year.
Market Cap
3.74B
Enterprise Value
4.08B
1-Year Change
12.59%
Global Rank
n/a
Country Rank
n/a
Category
ChartMarket Cap Chart
Since November 15, 2017, Telix Pharmaceuticals's market cap has increased from $115.28M to $3.74B, an increase of 3,148.53%. That is a compound annual growth rate of 47.76%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 13, 2026 | 3.74B | 47.99% |
| Dec 31, 2025 | 2.53B | -50.36% |
| Dec 31, 2024 | 5.10B | 129.18% |
| Dec 29, 2023 | 2.22B | 42.30% |
| Dec 30, 2022 | 1.56B | -2.70% |
| Dec 31, 2021 | 1.61B | 96.45% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Nov 15, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Edgewise Therapeutics | 4.24B |
| AbCellera Biologics | 4.07B |
| Tango Therapeutics | 4.01B |
| Relay Therapeutics | 3.92B |
| Legend Biotech | 3.61B |
| Xenon Pharmaceuticals | 3.53B |
| IDEAYA Biosciences | 3.48B |
| Acadia Pharmaceuticals | 3.41B |